All Stories

  1. Fatal massive hemolysis caused by immunoglobulin M anti-c antibody in a patient with newly diagnosed B-cell acute lymphoblastic leukemia: a case report
  2. At the Crossroads of Transfusion Medicine and Hemostasis
  3. Hemostatic Dysfunction in Liver Diseases
  4. Risk Factors, Diagnosis, Management, and Outcome of Splanchnic Vein Thrombosis: A Retrospective Analysis
  5. The New or Non–Vitamin K Antagonist Oral Anticoagulants: What Have We Learned Since Their Debut
  6. Meyer-Michel Samama, MD, PharmD (1927–2014)
  7. Age-Related Changes in Thrombosis and Hemostasis
  8. Thrombocytopenia in Older Adults
  9. From Fibrinolysis to the Plasminogen–Plasmin System and Beyond: A Remarkable Growth of Knowledge, with Personal Observations on the History of Fibrinolysis
  10. The Unique Hemostatic Dysfunction in Acute Promyelocytic Leukemia
  11. Cancer and Thrombosis—An Update
  12. The Unique Hemostatic Dysfunction in Acute Promyelocytic Leukemia
  13. The coagulopathy in acute promyelocytic leukaemia – What have we learned in the past twenty years
  14. Biologic Role of the Plasminogen-Plasmin System: Thrombolysis, Bleeding, and Beyond
  15. The Apparent uPA/PAI-1 Paradox in Cancer: More than Meets the Eye
  16. 190: Microparticle source and tissue factor expression in pregnancy
  17. Adverse Effects of Drugs on Hemostasis and Thrombosis
  18. Thrombotic and Bleeding Complications Associated with Chemotherapy
  19. Thrombosis in hematologic malignancies: risks and consequences
  20. Thrombosis and bleeding in cancer patients
  21. Microvascular Thrombosis: A Serious and Deadly Pathologic Process in Multiple Diseases
  22. Infection and Anemia
  23. Thromboembolic and bleeding complications in acute leukemia
  24. Microparticles in Thrombosis and Hemostasis
  25. Role of Microparticles in the Hemostatic Dysfunction in Acute Promyelocytic Leukemia
  26. The Significance of Endothelial Heterogeneity in Thrombosis and Hemostasis
  27. Under-Recognized Significance of Endothelial Heterogeneity: Hemostasis, Thrombosis, and Beyond
  28. The coagulopathy of acute promyelocytic leukaemia revisited
  29. The Plasminogen Activator System and Cancer
  30. The Role of Plasminogen-Plasmin System in Cancer
  31. A Tribute to Eberhard F. Mammen, M.D. (1930–2008)
  32. Hemostatic Dysfunction in Malignant Hematologic Disorders
  33. Adverse Effects on Hemostatic Function of Drugs Used in Hematologic Malignancies
  34. Incidence and Pathogenesis of Thrombosis in Hematologic Malignancies
  35. The Life and Vision of a Pioneer: A Tribute to Tage Astrup, D.Sc., Dr.Med.h.c.
  36. Thrombosis and bleeding in cancer patients
  37. The Clinical Spectrum of Thrombotic Thrombocytopenic Purpura
  38. Thrombotic Thrombocytopenic Purpura: A Diagnostic and Therapeutic Challenge
  39. Anticoagulant drugs: an update
  40. Bleeding and thrombosis in the cancer patient
  41. Thrombogenic role of cells undergoing apoptosis
  42. Abnormalities in hemostasis in acute promyelocytic leukemia
  43. Thrombotic Microangiopathy in the Cancer Patient
  44. The Hyperviscosity Syndromes
  45. Thrombotic Microangiopathy Manifesting as Thrombotic Thrombocytopenic Purpura/Hemolytic Uremic Syndrome in the Cancer Patient
  46. Thrombotic thrombocytopenic purpura after stenting and ticlopidine
  47. 48 uPA induces adhesion of tumor cells in vitro
  48. 50 Plasminogen activation system in tumor apoptosis
  49. Plasminogen-plasmin System in Tumor Invasion
  50. New Insights into the Pathogenesis of Coagulation Dysfunction in Acute Promyelocytic Leukemia
  51. The plasminogen-plasmin system in malignancy
  52. The biologic role of components of the plasminogen-plasmin system
  53. Components of the Plasminogen-Plasmin System in Human Tumor Cell Lines
  54. Fibrinolysis and Cancer
  55. Thrombotic Microangiopathy
  56. Fatal Thrombotic Thrombocytopenic Purpura despite Plasmapheresis
  57. Fibrinolytic activity in experimental intracerebral hematoma
  58. Tissue Plasminogen Activator and Inhibitors of Fibrinolysis in Malignant Melanoma
  59. Comparison of myointimal hyperplasia in laser-assisted and suture anastomosed arteries
  60. Aneurysm Formation after Low Power Carbon Dioxide Laser-assisted Vascular Anastomosis
  61. Anti‐Pr cold hemagglutination associated with livedo reticularis
  62. Thrombotic Thrombocytopenic Purpura and Hemolytic Uremic Syndrome in Pregnancy
  63. The Role of Fibrinolysis in Disease Processes
  64. Thrombotic Thrombocytopenic Purpura
  65. Platelet antithrombin activity
  66. Role of Fibrinolysis in Thrombotic Thrombocytopenic Purpura
  67. Fibrinolytic Activity in Lesions of Hereditary Hemorrhagic Telangiectasia
  68. Fibrinogen and its derivatives in relationship to ancrod and reptilase
  69. Inhibitors of fibrinolysis
  70. Inhibitors of Fibrinolysis in Platelets in Polycythaemia Vera and Thrombocytosis
  71. Plasminogen activator activity in cultures from human tissues. An immunological and histochemical study
  72. The Nature of the Vascular Lesion in Thrombotic Thrombocytopenic Purpura.